Clinical Trials Using Fresolimumab

Clinical trials are research studies that involve people. The clinical trials on this list are studying Fresolimumab. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Fresolimumab and Stereotactic Ablative Radiotherapy in Treating Patients with Stage IA-IB Non-small Cell Lung Cancer

    This phase I / II trial studies the side effects and best dose of fresolimumab when given with stereotactic ablative radiotherapy and to see how well they work in treating patients with stage IA-IB non-small cell lung cancer. Monoclonal antibodies, such as fresolimumab, may block tumor growth in different ways by targeting certain cells. Stereotactic body radiation therapy uses special equipment to position a patient and deliver radiation to tumors with high precision. This method can kill tumor cells with fewer doses over a shorter period and cause less damage to normal tissue. Giving fresolimumab with stereotactic ablative radiotherapy may work better in treating patients with early stage non-small cell lung cancer.
    Location: Stanford Cancer Institute Palo Alto, Palo Alto, California